by PVA_Admin | Sep 15, 2018 | Cold Plasma Publications, Publications
Treatment of Triple-Negative Breast Cancer Cells with the Canady Cold Plasma Conversion System: Preliminary Results Xiaoqian Cheng, Warren Rowe, Lawan Ly, Alexey Shashurin, Taisen Zhuang, Shruti Wigh,Giacomo Basadonna, Barry Trink, Michael Keidar, and Jerome Canady...
by PVA_Admin | Sep 7, 2018 | Cold Plasma Publications, Publications
The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner Warren Rowe, Xiaoqian Cheng, Lawan Ly, Taisen Zhuang, Giacomo Basadonna, Barry Trink, Michael Keidar, and Jerome Canady Malignant solid...
by PVA_Admin | Aug 22, 2018 | Other Publications, Publications
Comprehensive Clinical Plasma Medicine Hans-Robert Metelmann, Thomas von Woedtke, and Klaus-Dieter Weltmann Colorectal cancer (CRC) is the third most common cancer in the world and the second leading cause of cancer death in the United States. In 2012 an estimated...
by PVA_Admin | Jul 24, 2018 | 2018 Press Release, Press Release
US Patent Office Issues Decision to Grant Patent for USMI’s Cold Atmospheric Plasma for the Selective Ablation of Cancer Cells TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a U.S. FDA registered life science, biomedical and robotic...
by PVA_Admin | Jun 14, 2018 | 2018 Press Release, Press Release
US Patent Office Issues Patent for USMI’s Cold Atmospheric Plasma for the Treatment of Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a U.S. FDA registered life science and biomedical device company, and subsidiary of US Patent...
